Brief: Laboratorio Reig Jofre And Zendal Get Appointed By EU To Ensure Vaccine Production Capacity In Europe

Laboratorio Reig Jofre SA

30/06/2023 12:25

June 30 (Reuters) - Laboratorio Reig Jofre SA  RJFE.MC :
    * WITH ZENDAL APPOINTED BY EU TO ENSURE VACCINE PRODUCTION
CAPACITY IN EUROPE IN CASE OF FUTURE HEALTH EMERGENCIES
    * AGREEMENT SIGNED WITH EUROPEAN HEALTH AND DIGITAL
EXECUTIVE
AGENCY (HADEA)
    * EUROPEAN COMMISSION, THROUGH HADEA, INITIATED TENDER
PROCESS
WITH  AIM OF SECURING MANUFACTURING AND SUPPLY NETWORK ACROSS EU
AND EEA TO ENSURE EARLY AVAILABILITY OF VACCINES IN CASE OF A
PUBLIC HEALTH EMERGENCY
    * CAPACITY RESERVATION AGREEMENT HAS BEEN SIGNED WITH
INITIAL
DURATION OF FOUR YEARS
    * CONSORTIUM FORMED BY REIG JOFRE AND CZ VACCINES HAS BEEN
ONE OF
THE FOUR FINAL AWARDEES IN THIS PROCESS
    * HADEA HAS POSSIBILITY TO EXTEND THIS AGREEMENT FOR TWO
ADDITIONAL PERIODS, FOR MAXIMUM TOTAL DURATION OF EIGHT YEARS
    * REIG JOFRE WILL RESERVE UP TO 30% OF MAXIMUM ANNUAL
CAPACITY OF
ITS NEW INJECTABLES PLANT LOCATED IN BARCELONA TO MEET PROGRAM'S
REQUIREMENT
    * CZ VACCINES COMMITS TO RESERVING MANUFACTURING CAPACITY IN
ITS
PRODUCTION AREA IN O PORRINO TO PRODUCE VACCINE ACTIVE
INGREDIENT
    * IF RESERVED CAPACITY IS ACTIVATED DUE TO EMERGENCY, BOTH
COMPANIES COMMIT TO ENSURING SUPPLY CHAIN

Source text for Eikon:  ID:nCNM7Z66ly 
Further company coverage:  RJFE.MC 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))